Relative potencies of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls derived from hepatic porphyrin accumulation in mice

被引:37
作者
vanBirgelen, APJM
DeVito, MJ
Akins, JM
Ross, DG
Diliberto, JJ
Birnbaum, LS
机构
[1] UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA
[2] CLEMSON UNIV, CLEMSON, SC 29632 USA
关键词
D O I
10.1006/taap.1996.0103
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatic porphyrin accumulation was studied after subchronic dosing of female B6C3F1 mice by gavage with single congeners of polychlorinated or polybrominated dibenzo-p-dioxins (PCDDs, PBDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs). Quantitative hepatic porphyrin profile analyses in selected samples showed uroporphyrin and heptacarboxylporphyrin as the main porphyrins detected, Dose-dependent increases in total hepatic porphyrins were found for all congeners tested. At lower dose levels, relative potencies, based on administered dose as well as target tissue dose, of PCDDs, PCDFs, and coplanar PCBs, using 2,3,7,8-tetrachlorodibenzo-p-dioxin as a reference compound, were in the same range as those previously derived from the induction of hepatic CYP1A1 and CYP1A2 enzyme activities. CYP1A2 has been reported to be involved in the oxidation of uroporphyringen III to uroporphyrin III. All these facts suggest the involvement of an aryl hydrocarbon receptor-mediated mechanism in hepatic porphyrin accumulation, possibly via CYP1A2, However, the relative potencies of the mono-ortho-substituted PCBs were higher for hepatic porphyrin accumulation than for hepatic CYP1A1 and CYP1A2 induction. In addition, hepatic porphyrin accumulation was the highest after exposure to mono-ortho-PCBs. Since mono-ortho-substituted PCBs induce the phenobarbital-inducible CYP2B isoforms of cytochrome P450, an additional induction of delta-aminolevulinic acid synthetase may also contribute to hepatic porphyrin accumulation following subchronic exposure to these particular congeners. Relative potencies derived from hepatic porphyrin accumulation after PCDD, PCDF, or coplanar PCB administration are a useful tool in risk assessment. However, the higher relative potencies of the mono-ortho-substituted PCBs have important implications for risk assessment Of these compounds. (C) 1996 Academic Press, Inc.
引用
收藏
页码:98 / 109
页数:12
相关论文
共 66 条
[1]   IMPACT OF POLYCHLORINATED DIBENZO-P-DIOXINS, DIBENZOFURANS, AND BIPHENYLS ON HUMAN AND ENVIRONMENTAL-HEALTH, WITH SPECIAL EMPHASIS ON APPLICATION OF THE TOXIC EQUIVALENCY FACTOR CONCEPT [J].
AHLBORG, UG ;
BROUWER, A ;
FINGERHUT, MA ;
JACOBSON, JL ;
JACOBSON, SW ;
KENNEDY, SW ;
KETTRUP, AAF ;
KOEMAN, JH ;
POIGER, H ;
RAPPE, C ;
SAFE, SH ;
SEEGAL, RF ;
TUOMISTO, J ;
VANDENBERG, M .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1992, 228 (04) :179-199
[2]   TOXIC EQUIVALENCY FACTORS FOR DIOXIN-LIKE PCBS - REPORT ON A WHO-ECEH AND IPCS CONSULTATION, DECEMBER 1993 [J].
AHLBORG, UG ;
BECKING, GC ;
BIRNBAUM, LS ;
BROUWER, A ;
DERKS, HJGM ;
FEELEY, M ;
GOLOR, G ;
HANBERG, A ;
LARSEN, JC ;
LIEM, AKD ;
SAFE, SH ;
SCHLATTER, C ;
WAERN, F ;
YOUNES, M ;
YRJANHEIKKI, E .
CHEMOSPHERE, 1994, 28 (06) :1049-1067
[3]   Use of toxic equivalency factors for risk assessment for dioxins and related compounds [J].
Birnbaum, LS ;
DeVito, MJ .
TOXICOLOGY, 1995, 105 (2-3) :391-401
[4]  
BIRNBAUM LS, 1994, PROG CLIN BIOL RES, V387, P139
[5]   TERATOGENIC EFFECTS OF POLYCHLORINATED DIBENZOFURANS IN COMBINATION IN C57BL/6N MICE [J].
BIRNBAUM, LS ;
HARRIS, MW ;
CRAWFORD, DD ;
MORRISSEY, RE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 91 (02) :246-255
[6]  
BIRNBAUM LS, 1993, ORGANOHALOGEN COMPOU, V13, P141
[7]   INDUSTRIALLY ACQUIRED PORPHYRIA [J].
BLEIBERG, J ;
BRODKIN, R ;
WALLEN, M ;
APPLEBAUM, IL .
ARCHIVES OF DERMATOLOGY, 1964, 89 (06) :793-+
[8]   RAT-LIVER ALTERATIONS AFTER CHRONIC TREATMENT WITH HEXACHLOROBENZENE [J].
BOGER, A ;
KOSS, G ;
KORANSKY, W ;
NAUMANN, R ;
FRENZEL, H .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1979, 382 (02) :127-137
[9]  
BOWERS MA, 1992, J LAB CLIN MED, V120, P272
[10]   DISPOSITION AND EXCRETION OF 2,3,4,7,8-PENTACHLORODIBENZOFURAN IN THE RAT [J].
BREWSTER, DW ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 90 (02) :243-252